Gamuda's Order Book: HLIB Research Shares Insights

Chartdata

You need 2 min read

·

Post on Oct 27, 2024

50 visitor like this post

Share

Gamuda's Order Book: HLIB Research Shares Insights

So, you wanna know what's up with Gamuda's order book? HLIB Research has some juicy insights. Let's dive in!

What's the Deal?

Gamuda is a big player in the construction game, and their order book is a key indicator of future earnings. HLIB Research recently released a report with some interesting observations about Gamuda's current order book situation.

The Lowdown on Gamuda's Order Book

The good news: Gamuda's order book is looking pretty healthy. It's currently sitting at RM18.7 billion, which is enough to keep them busy for the next few years.

The bad news: HLIB Research notes that Gamuda's order book has shrunk a bit in recent months. This is mainly due to the completion of some big projects. However, they believe the order book is still robust and should support earnings going forward.

What About New Projects?

HLIB Research is optimistic about Gamuda's future pipeline. They expect new projects, like the MRT3 project, to start contributing to the order book soon. This would be a major boost for Gamuda.

What Does It All Mean for Investors?

HLIB Research maintains a "Buy" recommendation on Gamuda shares. They believe the company's solid order book, strong track record, and potential for new projects make it a good investment.

A Few Things to Keep in Mind:

• Competition: Gamuda faces stiff competition in the construction industry.
• Government Policies: Government policies can impact construction projects, so keep an eye on those.
• Economic Conditions: The overall economic climate can influence construction activity.

The Takeaway:

Gamuda's order book is still looking pretty good, and HLIB Research is bullish on the company's future prospects.

Remember, this is just one perspective. Always do your own research before making any investment decisions.

Keywords: Gamuda, Order Book, HLIB Research, Construction, MRT3, Earnings, Investment, Buy Recommendation, Stock Market

This article was written for informational purposes only and should not be considered financial advice.